Wandercraft Acquired Exoskeleton Firm Ekso Bionics
Wandercraft purchased Ekso Bionics from ChronoScale Holdings to expand its global robotics and mobility footprint.
Updated on Oct. 1, 2026 in Healthcare
Live Poll
Do you trust that consolidation among medical robotics companies improves care options for patients?
Wandercraft completed the acquisition of Ekso Bionics from a subsidiary of ChronoScale Holdings Corporation. The deal, which was unanimously approved by both boards, aims to combine complementary technologies in robotic mobility.
Why it matters
The merger seeks to increase product distribution and unify clinical experience to expand global market access for exoskeleton technology. By combining resources, the companies intend to advocate for broader international coverage for wearable mobility devices.
The combined entity now supports patients at more than 700 rehabilitation centers. Currently, 150 of these research and clinical sites utilize the Atalante X exoskeleton platform.
The players
Wandercraft
An international robotics firm specializing in personal exoskeletons that maintains an operational hub in New York.
Ekso Bionics
A robotic mobility company based in San Rafael, California, known for developing devices used in rehabilitation centers.
ChronoScale Holdings Corporation
The parent organization that previously owned the subsidiary division of Ekso Bionics before the recent divestiture.
The details
The acquisition closed on October 1, 2026, with the companies integrating their respective technologies and access teams. These teams will continue to assist users with reimbursement, clinical documentation, and financing, including managing claims under HCPCS code K1007.
Timeline
The acquisition of Ekso Bionics was officially completed on October 1, 2026.
Market Landscape
This deal aligns with a trend of industry consolidation aimed at standardizing clinical robotic mobility solutions. It positions the combined firm to compete more effectively in the international market by leveraging established billing protocols like Medicare HCPCS code K1007.
Patients currently utilizing these systems may see streamlined support for reimbursement and documentation through the combined company's specialized access teams. The acquisition is intended to eventually increase the availability of robotic mobility options for individuals requiring rehabilitation services.
The takeaway
The merger highlights the growing importance of combining specialized robotic hardware with robust administrative support systems to navigate complex healthcare billing. Integration of these technologies often provides patients with more consistent access to advanced mobility tools across different clinical settings.
Further reading
Learn more about the latest innovations and corporate shifts within the Healthcare sector.
Live Poll
Do you trust that consolidation among medical robotics companies improves care options for patients?
